Ick Chan Kwon is currently Head of Biomedical Research Center at Korea Institute of Science and Technology (KIST). He received his B.S. and M.S. degrees from the College of Engineering at Seoul National University in 1982 and 1984 and his Ph. D. in pharmaceutics and pharmaceutical chemistry from University of Utah in 1993. After a post-doctoral training in Center for Controlled Chemical Delivery at University of Utah, he joined KIST in 1994.
He is currently a vice president of the Korean Society of Molecular Imaging (2005-2006, 2007-2008). He also serves as an Associate Editor of the Journal of Controlled Release, Asian Editor of the Journal of Biomedical Nanotechnology and a member of editorial boards of Journal of Biomedical Engineering Research, Macromolecular Research, and J. Biomaterials Science, Polymer Edition.
His main research interest is targeted drug delivery with polymeric nanoparticles and is now expanding to the development of smart nano-probes for theragnostic imaging. He is a project leader of “Real-time molecular imaging” supported from the Ministry of Science and Technology of Korea. He has published over 100 peer-reviewed papers, 11 book chapters, and 6 review articles. He also made over 60 national as well as international invited lectures.
How did you first hear about nanoHUB?
What is the primary purpose of your visit to nanoHUB?